A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
A phase I, single-center, double-blind, randomized, placebo-controlled, safety and pharmacokinetic study to evaluate systemic and local vaginal exposure to lidocaine and prilocaine and the metabolites, 2,6-dimethylaniline (2,6-DMA) and o-toluidine, in female healthy volunteer subjects following daily application of 60 mg PSD502 or placebo to the vagina and cervix for seven days
Epistemonikos ID: 39d033fabba56debf0d53fa62fc3ff3a747931a6
First added on: May 05, 2024